Security key
433000106
Hims & Hers Health, Inc. - Common Stock (HIMS)
CUSIP: 433000106
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 135,555,935
- Total 13F value
- $2,737,194,047
- Share change
- +8,319,910
- Put/Call ratio
- 56%
- SEC-reported price per share
- $20.19
- Number of holders
- 291
- Value change
- +$237,895,932
- Number of buys
- 195
- Number of sells
- 104
- Shares outstanding
- 225,153,219
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
291
Top holders
10
HIMS full security history
Ownership snapshot
Full 13F holder table
Hims & Hers Health, Inc. SEC filings
Hims & Hers Health, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of HIMS - Hims & Hers Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Institutional Venture Man...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $221,378,670
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $221.38M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
Institutional Venture Management ...
$135.97M
Jack Abraham
$69.43M
VANGUARD GROUP INC
$221.38M
BlackRock Finance, Inc.
$168.01M
Jules A. Maltz
$138.02M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Institutional Venture Management XV, LLC |
3/4/5
13F
10%+ Owner · Company
|
—
denominator unverified
|
$135,972,241
15,451,391 shares
|
— | 02 Mar 2023 |
| Jack Abraham |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$69,430,248
7,889,801 shares
|
— | 14 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$221,378,670
14,310,192 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$168,011,812
10,860,492 shares
|
— | 31 Mar 2024 |
| Jules A. Maltz |
3/4/5
Director
|
—
denominator unverified
|
$138,018,699
15,683,943 shares
|
— | 01 Jun 2023 |
| MARSHALL WACE, LLP |
13F
Company
|
—
denominator unverified
|
$87,254,357
5,640,230 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
291
Shares
135,555,935
Rows available
291
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
236
Q2 2024 holders
291
Holder diff
55
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|